The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD

Sodium–glucose cotransporter 2 inhibitors (SGLT2i) exhibit renoprotective effect in patients with chronic kidney disease (CKD) and reduce serum uric acid (UA) in patients with diabetes mellitus. However, it is not clarified whether SGLT2i reduce serum UA levels in patients with advanced CKD. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwata, Yukimasa, Notsu, Shoki, Kawamura, Yushi, Mitani, Waka, Tamai, Shinjiro, Morimoto, Madoka, Yamato, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039024/
https://www.ncbi.nlm.nih.gov/pubmed/36964174
http://dx.doi.org/10.1038/s41598-023-32072-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039024/
https://www.ncbi.nlm.nih.gov/pubmed/36964174
http://dx.doi.org/10.1038/s41598-023-32072-y

Ejemplares similares